
Assoc Prof In Res
M_MED-CORE-CARD
CLINICAL INTERESTS: Dr. Ethan Weiss is a cardiologist specializing in general cardiology. His special interests include preventive cardiology, genetics of coronary disease, risk assessment, and heart disease in the young.
RESEARCH INTERESTS: In his research, Dr. Weiss uses genetic models to better understand the mechanism of metabolic disorders such as obesity, fatty liver disease, and diabetes. He also studies the blood clotting system and has interest in identifying novel ways to safely block clots associated with diseases such as heart attack and stroke without causing an increase in bleeding.
Publications
Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studies.
Lancet (London, England)
Relationship of Fat Mass Ratio, a Biomarker for Lipodystrophy, With Cardiometabolic Traits.
Diabetes
An evolutionary trade-off between host immunity and metabolism drives fatty liver in male mice.
Science (New York, N.Y.)
Three-dimensional optical body shape and features improve prediction of metabolic disease risk in a diverse sample of adults.
Obesity (Silver Spring, Md.)
Use of an mHealth Ketogenic Diet App Intervention and User Behaviors Associated With Weight Loss in Adults With Overweight or Obesity: Secondary Analysis of a Randomized Clinical Trial.
JMIR mHealth and uHealth
Assessment of clinical measures of total and regional body composition from a commercial 3-dimensional optical body scanner.
Clinical nutrition (Edinburgh, Scotland)
Effect of carbohydrate-restricted dietary interventions on LDL particle size and number in adults in the context of weight loss or weight maintenance: a systematic review and meta-analysis.
The American journal of clinical nutrition
Keyto App and Device versus WW App on Weight Loss and Metabolic Risk in Adults with Overweight or Obesity: A Randomized Trial.
Obesity (Silver Spring, Md.)
A Mediterranean-Based Ketogenic Diet Application Compared to a Calorie-Restricted Low-Fat Diet Application on Cardiometabolic Risk in Adults With Overweight or Obesity.
Current Developments in Nutrition
Caution Against Overinterpreting Time-Restricted Eating Results-Reply.
JAMA internal medicine
4ß-hydroxycholesterol is a pro-lipogenic factor that promotes SREBP1c expression and activity through Liver X-receptor.
Journal of lipid research
Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical Trial.
JAMA internal medicine
Comparing the Keyto App and Device with Weight Watchers' WW App for Weight Loss: Protocol for a Randomized Trial.
JMIR research protocols
Diet Quality and Visceral Adiposity among a Multiethnic Population of Young, Middle, and Older Aged Adults.
Current Developments in Nutrition
MON-LB107 Treat: A Randomized Controlled Trial Examining the Effects of Time Restricted Eating on Weight Loss and Metabolic Markers.
Journal of the Endocrine Society
Billy Idol.
Perspectives in biology and medicine
Adipocyte JAK2 mediates spontaneous metabolic liver disease and hepatocellular carcinoma.
JCI insight
Growth hormone receptor antagonism with pegvisomant in insulin resistant non-diabetic men: A phase II pilot study.
F1000Research
Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice.
Endocrinology
Disruption of JAK2 in adipocytes impairs lipolysis and improves fatty liver in mice with elevated GH.
Molecular endocrinology (Baltimore, Md.)
HIV infection is associated with decreased thrombin generation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Liver-derived IGF-I contributes to GH-dependent increases in lean mass and bone mineral density in mice with comparable levels of circulating GH.
Molecular endocrinology (Baltimore, Md.)
Abrogation of growth hormone secretion rescues fatty liver in mice with hepatocyte-specific deletion of JAK2.
The Journal of clinical investigation
Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development.
Arteriosclerosis, thrombosis, and vascular biology
Sex differences in thrombosis.
Expert review of hematology
Sex differences in thrombosis in mice are mediated by sex-specific growth hormone secretion patterns.
The Journal of clinical investigation
Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin.
The Journal of biological chemistry
Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function.
The Journal of biological chemistry
Higher prevalence of GPIIIa PlA2 polymorphism in siblings of patients with premature coronary heart disease.
Archives of pathology & laboratory medicine
PlA1/A2 polymorphism of platelet glycoprotein IIIa and risk of cardiovascular disease.
Lancet (London, England)
Self-expanding metal stent for obstructing adenocarcinoma of the sigmoid.
Gastrointestinal endoscopy
A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.
The New England journal of medicine